Publications by authors named "I D Fedoniuk"

Background: Neuronal ceroid lipofuscinoses (NCLs) are a group of neurodegenerative disorders characterized by an accumulation of lipofuscin in the body's tissues. NCLs are associated with variable age of onset and progressive symptoms including seizures, psychomotor decline, and loss of vision.

Methods: We describe the clinical and molecular characteristics of four Russian patients with NCL (one female and three males, with ages ranging from 4 to 5 years).

View Article and Find Full Text PDF
Article Synopsis
  • A study followed 722 epileptic patients (ages 3 months to 57 years) treated with topiramate from 2002-2012, with 64.4% showing effectiveness, particularly better in those on monotherapy (72.2%) compared to combined therapy (61.9%).
  • In pediatric and adult populations, topiramate demonstrated high efficacy (67.3% for children and 82.1% for adults) and lower rates of aggravation as age increased.
  • Drug compliance over a year was noted at 60.7%, with varying efficacy levels among different age groups, indicating topiramate's potential as an effective treatment for certain epilepsy forms.
View Article and Find Full Text PDF

Syndrome Leigh (SL) or subacute necrotizing encephalomyelopathy - is a rare hereditary genetically heterogeneous disease from the group of mitochondrial encephalomyopathies. Twenty-seven children with SL were examined using clinical, laboratory (measuring lactate levels), MRI and molecular-genetic (polymerase chain reaction genotyping of 9 exons of the SURF1 gene) studies. The mean age of manifestation was 11,6 months.

View Article and Find Full Text PDF

To study clinical peculiarities of parainfectious opsoclonus-myoclonus syndrome (OMS) in children and to elaborate approaches to its pharmacotherapeutic correction, 20 children, including 12 girls and 8 boys, have been examined using neurological, neurophysiological, immunological and virological methods along with magnetic resonance tomography (MRT). Age-at-disease-onset was from 8 months to 3 years old. The development of neurological symptoms was related to a virus infection (55% of cases) or vaccination (15%).

View Article and Find Full Text PDF